AlphaGrep UK Ltd’s Steris STE Stock Holding History

AlphaGrep UK Ltd’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$477K	Buy	2,159 +1,009	+88%	+$247K	0.14%	269
2025 Q4	$292K	Buy	+1,150	New	+$289K	0.1%	447

Other funds holding STE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

AlphaGrep UK Ltd's STE Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Steris (STE) stake by 88% in Q1 2026, buying an estimated $247K and bringing the position to 2,159 shares worth $477K. The position accounts for 0.14% of the portfolio, ranked #269.

AlphaGrep UK Ltd first reported a position in STE in Q4 2025 and has held it in 2 quarters since. 844 funds tracked by Wall St. Rank hold STE as of Q1 2026.

AlphaGrep UK Ltd held 2,159 shares of Steris worth $477K as of Q1 2026.
AlphaGrep UK Ltd bought 1,009 Steris shares in Q1 2026, an estimated $247K.
Steris made up 0.14% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #269 holding.
AlphaGrep UK Ltd first reported a position in Steris in Q4 2025 and has held it in 2 quarters since.
844 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.